Dismissed on Apr 22, 2022
Rochester Drug Co-Operative is in post-confirmation liquidation: its Second Amended Chapter 11 Plan of Liquidation was confirmed in February 2021 and became effective on March 19, 2021. The case has therefore moved beyond an operating reorganization and interim financing posture to implementation of the confirmed liquidation framework, with no future hearing milestones identified in the supplied record.
Updated Sep 5, 9:31 AM ET
Certificate of Service RE: Chapter 11 Post Confirmation Report for Quarter Ending 3/31/2026 Filed on behalf of Liquidator Advisory Trust Group, LLC, solely in its capacity as Liquidating Trustee of the RDC Liquidating Trust. (RE: related document(s)[2192] Ch. 11 Post-Confirmation Report) Filed by Attorney (Scharf, Ilan)
Dkt. 2193 · Apr 22, 2026
Chapter 11 Post-Confirmation Report for the Quarter Ending: 3/31/2026 Filed on behalf of Liquidator Advisory Trust Group, LLC, solely in its capacity as Liquidating Trustee of the RDC Liquidating Trust. Filed by Attorney (Scharf, Ilan)
Dkt. 2192 · Apr 22, 2026
Notice of Appearance and Request for Notice by Christopher Anton of FBT Gibbons LLP. Filed on behalf of Creditor Novo Nordisk, Inc., Notice ...
Dkt. 2191 · Mar 13, 2026
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.